323 related articles for article (PubMed ID: 31361907)
1. Immune-related adverse events in the gastrointestinal tract: diagnostic utility of upper gastrointestinal biopsies.
Zhang ML; Neyaz A; Patil D; Chen J; Dougan M; Deshpande V
Histopathology; 2020 Jan; 76(2):233-243. PubMed ID: 31361907
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Inhibitor-Induced Upper Gastrointestinal Tract Inflammation Shows Morphologic Similarities to, but Is Immunologically Distinct From, Helicobacter pylori Gastritis and Celiac Disease.
Irshaid L; Robert ME; Zhang X
Arch Pathol Lab Med; 2021 Feb; 145(2):191-200. PubMed ID: 33501492
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies.
Collins M; Michot JM; Danlos FX; Mussini C; Soularue E; Mateus C; Loirat D; Buisson A; Rosa I; Lambotte O; Laghouati S; Chaput N; Coutzac C; Voisin AL; Soria JC; Marabelle A; Champiat S; Robert C; Carbonnel F
Ann Oncol; 2017 Nov; 28(11):2860-2865. PubMed ID: 29045560
[TBL] [Abstract][Full Text] [Related]
4. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors.
Dougan M; Blidner AG; Choi J; Cooksley T; Glezerman I; Ginex P; Girotra M; Gupta D; Johnson D; Shannon VR; Suarez-Almazor M; Anderson R; Rapoport BL
Support Care Cancer; 2020 Dec; 28(12):6129-6143. PubMed ID: 32856210
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival.
Yamada K; Sawada T; Nakamura M; Yamamura T; Maeda K; Ishikawa E; Iida T; Mizutani Y; Kakushima N; Ishikawa T; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Furune S; Hase T; Yokota K; Maeda O; Hashimoto N; Akiyama M; Ando Y; Fujishiro M
World J Gastroenterol; 2021 Nov; 27(41):7190-7206. PubMed ID: 34887637
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review.
Daniels JA; Lederman HM; Maitra A; Montgomery EA
Am J Surg Pathol; 2007 Dec; 31(12):1800-12. PubMed ID: 18043034
[TBL] [Abstract][Full Text] [Related]
7. Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors.
de Malet A; Antoni G; Collins M; Soularue E; Marthey L; Vaysse T; Coutzac C; Chaput N; Mateus C; Robert C; Carbonnel F
Eur J Cancer; 2019 Jan; 106():106-114. PubMed ID: 30476730
[TBL] [Abstract][Full Text] [Related]
8. An Investigation of Nine Patients with Gastrointestinal Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors.
Miyahara K; Noda T; Ito Y; Hidaka H; Fujimoto S; Takedomi H; Akutagawa T; Sakata Y; Shimamura T; Tominaga N; Yamaguchi D; Fujimoto K
Digestion; 2020; 101(1):60-65. PubMed ID: 31801131
[TBL] [Abstract][Full Text] [Related]
9. Pathologic Manifestations of Gastrointestinal and Hepatobiliary Injury in Immune Checkpoint Inhibitor Therapy.
Patil PA; Zhang X
Arch Pathol Lab Med; 2021 May; 145(5):571-582. PubMed ID: 32338534
[TBL] [Abstract][Full Text] [Related]
10. Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.
Coutzac C; Adam J; Soularue E; Collins M; Racine A; Mussini C; Boselli L; Kamsukom N; Mateus C; Charrier M; Cassard L; Planchard D; Ribrag V; Fizazi K; Loriot Y; Lepage P; Scoazec JY; Robert C; Carbonnel F; Chaput N
J Crohns Colitis; 2017 Oct; 11(10):1238-1246. PubMed ID: 28967957
[TBL] [Abstract][Full Text] [Related]
11. Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents.
Weber JS; Postow M; Lao CD; Schadendorf D
Oncologist; 2016 Oct; 21(10):1230-1240. PubMed ID: 27401894
[TBL] [Abstract][Full Text] [Related]
12. Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors.
Tang T; Abu-Sbeih H; Luo W; Lum P; Qiao W; Bresalier RS; Richards DM; Wang Y
Scand J Gastroenterol; 2019 May; 54(5):538-545. PubMed ID: 31079556
[No Abstract] [Full Text] [Related]
13. Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases.
Leung ST; Chandan VS; Murray JA; Wu TT
Am J Surg Pathol; 2009 May; 33(5):788-98. PubMed ID: 19295410
[TBL] [Abstract][Full Text] [Related]
14. Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?
Michot JM; Lazarovici J; Tieu A; Champiat S; Voisin AL; Ebbo M; Godeau B; Michel M; Ribrag V; Lambotte O
Eur J Cancer; 2019 Nov; 122():72-90. PubMed ID: 31634647
[TBL] [Abstract][Full Text] [Related]
15. Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review.
Khoja L; Day D; Wei-Wu Chen T; Siu LL; Hansen AR
Ann Oncol; 2017 Oct; 28(10):2377-2385. PubMed ID: 28945858
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolic acid (cellcept and myofortic) induced injury of the upper GI tract.
Nguyen T; Park JY; Scudiere JR; Montgomery E
Am J Surg Pathol; 2009 Sep; 33(9):1355-63. PubMed ID: 19542873
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitor-induced gastrointestinal and hepatic injury: pathologists' perspective.
Karamchandani DM; Chetty R
J Clin Pathol; 2018 Aug; 71(8):665-671. PubMed ID: 29703758
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic Features of Colitis Due to Immunotherapy With Anti-PD-1 Antibodies.
Chen JH; Pezhouh MK; Lauwers GY; Masia R
Am J Surg Pathol; 2017 May; 41(5):643-654. PubMed ID: 28296676
[TBL] [Abstract][Full Text] [Related]
19. [Managing the Adverse Effects Related to Immune Checkpoint Inhibitors].
Kuo HH; Chen WW
Hu Li Za Zhi; 2018 Jun; 65(3):88-95. PubMed ID: 29790143
[TBL] [Abstract][Full Text] [Related]
20. Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
De Martin E; Michot JM; Papouin B; Champiat S; Mateus C; Lambotte O; Roche B; Antonini TM; Coilly A; Laghouati S; Robert C; Marabelle A; Guettier C; Samuel D
J Hepatol; 2018 Jun; 68(6):1181-1190. PubMed ID: 29427729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
